Skip to content

Protalix BioTherapeutics, Inc.

PLX NYSE SEC CIK 1006281

Follow Protalix BioTherapeutics Weekly email: filings, results, news

News

2 stories filed under Protalix BioTherapeutics, grouped into ongoing threads

Call

Thread · 2 stories

Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary

Earnings 42 d ago

Protalix BioTherapeutics, Inc. (PLX) Q2 2026 Earnings Call Transcript

Earnings 43 d ago

Profile

Headquarters: HACKENSACK, NJ, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator